Refusal of Recommended Vaccines
Patient
Name _____________________________________________________
Birth date _________________
As the parent/guardian of __________________________, I
have investigated the risks and benefits of the following
vaccines and diseases. I am aware that there are documented
cases of people contracting diseases for which they are
clinically fully immunized and that the manufacturers of
the vaccines do not guarantee 100% efficacy. I am also
aware that VAERS (Vaccine Adverse Events Reporting System)
documented cases of over 350.720 adverse reactions from
vaccines from it’s inception through June 30, 2009. Every
credible authority from both sides of the issue agrees that
less than 10% of vaccine adverse events are reported to
VAERS! The number of vaccine adverse reports filed per in
each calendar year continues to climb. The Vaccine Injury
Compensation Program (The Vaccine Court) received 13,076
petitions for compensation from 1988 to July 7, 2009. The
National Vaccine Injury Fund, created in 1986 to compensate
families of vaccine-damaged children, has paid out over
1.844 billion dollars in compensation to date (July, 2009).
POLIO: I have been informed of the risk of my child
developing paralytic disease and meningitis associated with
poliomyelitis. I understand that even under epidemic
conditions, natural polio produces no symptoms in over 90%
of those exposed to it. (1) I understand that there have
been no cases of wild polio in the US in the last 25 years
and that those cases that have been documented have been
caused by the vaccine.(2)
I understand the following side effects for the vaccine are
possible: Ipol and Poliovax (Killed virus): temperature of
≥102°f in up to 38%, sleepiness, fussiness, crying,
decreased appetite, vomiting, Guillain-Barré Syndrome and
allergic reaction in those allergic to neomycin, polymyxin
B and streptomycin. Precautions include those who had a
previous negative reaction, pregnant women, and possibly
those with HIV/AIDS or otherwise compromised immune
systems. The live virus vaccine is no longer used in the
US. Reactions include contraction of polio by those who
have received the virus and by those who have come into
contact with body fluids and wastes of the immunized
person. Paralytic symptoms may follow contraction of polio.
Live virus is shed for up to 8 weeks after the inoculation.
Guillain-Barré Syndrome also has been noted. Not
recommended for use in households where someone has a
compromised immune system, for pregnant women, or where a
previous reaction has been reported.(3)
Ipol is grown on monkey kidney cells, contains
formaldehyde, and triple antibiotics. Poliovax is grown on
cells from an aborted baby, contains formaldehyde, cow
serum and triple antibiotic solution.(4) The monkey kidney
cells used in the original killed polio vaccine contains
SV-40 and has been found in tumor cells of children whose
parent's were vaccinated against polio using the
contaminated virus.(5) The live vaccine is grown on monkey
kidney cells, antibiotics and calf serum.
HEMOPHILUS INFLUENZAE B (Hib): I have been informed of the
risk of my child developing meningitis (although this
vaccine will not protect the child from meningitis from all
other forms such as pneumococcus, and meningococcus,
viruses, and fungi), pneumonia, and infections of the
blood, joints, bone, and soft tissue associated with
Hemophilus Influenzae B. I understand that this disease is
most likely in children up to 15 months of age and is fatal
in 3-6% of children who contract it. Incidence of this
disease today is low and the vaccine has not proven to be
highly effective in 41% of cases, according to some
studies.(6) Treatment is available.
The vaccine is often combined with the DTaP which has the
highest adverse event rate of any vaccine available today.
Reactions include: contracting Hib, localized pain,
erythema and induration, fever >100.6°f, irritability,
lethargy, anorexia, rhinorrhea, diarrhea, vomiting, cough,
when administered alone. Reactions occurred in up to 30% of
patients. When administered in conjunction with the DTaP,
reactions include local tenderness erythema and induration,
fever >100.8°f, irritability, drowsiness, anorexia,
diarrhea, vomiting, persistent crying, seizures, urticaria,
hives, renal failure, Guillain-Barré Syndrome and death.
Reactions occurred in up to 77.9% of patients.(7)
The vaccine contains yeast and diphtheria toxoid when given
alone.(8) It no longer contains thimerosal.
PERTUSSIS: I have been informed of the risk of my child
developing whooping cough, pneumonia, convulsions,
inflammation of the brain, and death associated with
pertussis. I understand the disease is rarely fatal, with a
99.8% recovery rate. It is most serious and
life-threatening in children under 6 months old, but there
are adequate methods of treatment available.(9)
The Pertussis vaccine (single antigen) may cause: fevers
>106°f, pain, swelling, diarrhea, projectile vomiting,
excessive sleepiness, high-pitched screaming, inconsolable
crying bouts, seizures, convulsions, collapse, shock,
breathing problems, brain damage and SIDS. One in 600
suffered a severe reaction in one study (10) and 1 in 875
suffered shock-collapse and convulsions.(11) Those in the
2nd study were tracked only for the first 48 hours
following immunization. A more recent study indicates that
1 in 100 react with convulsions, collapse, or high-pitched
screaming and 1 in 3 of those cases sustained permanent
brain damage.(12) In a study of 103 children who died of
SIDS, 70% died within 3 weeks of the DPT vaccine and 37% of
those died within the first week.(13)
The DTaP is recommended as a safer option than the original
DTP vaccination. Side effects of the DTaP were only tracked
for 72 hours and included: tenderness, erythema,
induration, fever >102.2°f, drowsiness, fretfulness,
vomiting, upper respiratory infection, diarrhea, rash,
febrile seizures, persistent or unusual crying, lethargy,
hypronic-hyporesponsive episode, urticaria, anaphylactic
shock, convulsions, encephalopathy, mono- and
polyneuropathies and death.(14) A new 5-in-1 vaccine is
available which combines the DTaP with HepB and Polio.
The vaccine contains formaldehyde, and aluminum
phosphate.(15) Tripedia and Pediarix (5-in-1) still contain
thimerosal.
DIPHTHERIA: I have been informed of the risk of my child
developing paralysis, heart failure, or respiratory failure
associated with diphtheria. I also have been informed that
there have been only 5 cases reported annually since
1980.(16) I also am aware that diphtheria is rarely fatal
and can be treated with antibiotics and bed rest. (17)
The Diphtheria component is most often given within the
DTaP or the DTaP/HepB/IPV and includes the same side
effects and reactions as those listed for pertussis.
Tripedia, Pediarix, and all available DT and Td vaccines
still contain thimerosal except for the TD made by Aventis
Pasteur Ltd.
TETANUS: I have been informed of the risk of my child
developing fatal neuromuscular disease related to tetanus.
I understand that the incidence of tetanus is low, and
there is an antitoxin, should we decline the immunization.
I understand that contracting tetanus does not provide
lifelong immunity, and neither does the vaccine. I
understand that to prevent more severe reactions from the
vaccine, the tetanus component has been so significantly
"diluted" that it is clinically ineffective.(18) I
understand that the death rate for properly treated cases
of tetanus may be as high as 20%.(19)
Side effects of the tetanus vaccine alone include: high
fever, pain, recurrent abscess formation, inner ear nerve
damage, demyelinating neuropathy, anaphylactic shock and
loss of consciousness.(20)
Tetanus given in the DTaP or the DTaP/HepB/IPV shot include
the same side effects and reactions as those listed for
pertussis. Tripedia, Pediarix, and all available DT and Td
vaccines still contain thimerosal except for the TD made by
Aventis Pasteur Ltd. The Tetanus toxoid also contains
thimerosal.
RUBEOLA (MEASLES): I have been informed of the risk of my
child developing pneumonia, encephalitis (inflammation of
the brain), and degenerative disease of the nervous system
with convulsions (subacute sclerosing panencephalitis)
related to rubeola. I understand the death rate for measles
is .03 in 100,000.(21) I understand that since 1984, over
55% of documented, confirmed cases of measles have been in
fully immunized persons.(22)
I understand that the greatest risk of the measles vaccine
may be to push the incidence of this disease into the late
teens and adulthood where it is more likely to be fatal or
cause more adverse and long-term effects.(23)
The measles vaccine is a live vaccine, and carries the risk
that it will cause the patient to contract measles. Other
adverse reactions include: stinging or burning at the
injection site, anaphylaxis, fever up to one month
following injection, rash, cough, rhinitis, erythema
multiforme, lymphadenopathy, urticaria, diarrhea, febrile
convulsions, seizures, thrombocytopenia, purpura,
vasculitis, optic neuritis, retrobulbar neuritis,
papillitis, retinitis, encephalitis and encephalopathy,
ocular palsies, Guillain-Barré Syndrome, ataxia, and
subacute sclerosing panencephalitis.(24)
Measles vaccine is most often given as a part of the MMR
which includes the following side effects: burning or
stinging at injection site, malaise, sore throat, cough,
rhinitis, headache, dizziness, fever, rash, nausea,
vomiting, diarrhea, erythema, induration, tenderness,
lymphadenopathy, parotitius, orchitis, nerve deafness,
thrombocytopenia, purpura, allergic reactions, urticaria,
polyneuritis, arthralgia, arthritis, anaphylaxis,
vasculitis, otitis media, conjunctivitis, febrile
convulsions, seizures, syncope, erythema multiforme, optic
neuritis, retrobulbar neuritis, papillitis, retinitis,
encephalitis and encephalopathy, ocular palsies,
Guillain-Barré Syndrome, ataxia, subacute sclerosing
panencephalitis,(25) and some recent studies indicate there
may be a link between the MMR (measles/mumps/rubella)
vaccine and autism and irritable bowel syndrome.(26)
Measles vaccine contains chick embryo cells, neomycin,
sorbitol and hydrolyzed gelatin. MMR contains all live
viruses, chick embryo, aborted fetal cells, neomycin,
sorbitol and hydrolyzed gelatin.(27)
MUMPS: I have been informed of the risk of my child
developing inflammation of the testicles, joints, kidneys,
and/or thyroid, and hearing impairment related to mumps. I
understand that mumps is rarely harmful in childhood, and
that most of the above risks occur when mumps is contracted
in adolescence or adulthood.(28)
I understand that there is a Mumps vaccine which poses the
following risks: contraction of mumps from the live
vaccine, burning or stinging at the injection site,
anaphylaxis, cough, rhinitis, fever, diarrhea, vasculitis,
parotitis, orchitis, purpura, urticaria, erythema
multiforme, optic neuritis, retrobulbar neuritis, syncope,
encephalitis, febrile seizures, and nerve deafness.(29)
Mumps usually is given in the MMR and may cause those side
effects and adverse reactions as noted in the measles
section above.
Mumps vaccine is live and should not be given to pregnant
women. It is cultured in chick embryos and contains
sorbitol and hydrolyzed gelatin.(30)
RUBELLA (GERMAN MEASLES): I have been informed of the risk
of my child developing inflammation of the brain or joints,
and of the risk of birth defects (including eye defects,
heart defects, deafness, mental retardation, growth
failure, jaundice, and disorders of blood clotting) in
infants born to mothers who contract rubella during
pregnancy, related to rubella. Therefore, I understand that
the greatest risk to my child may be if she never contracts
rubella as a child, but when she is pregnant and it damages
her unborn child. If she contracts rubella in childhood,
she is immune for life, and prior to the vaccine 85% of the
US population was immune.(31) I understand that if she is
not immune as an adult, she can choose to take the vaccine
prior to becoming pregnant. I understand that many of those
who contract rubella have been immunized (up to 80%). (32)
Adverse reactions among teenage girls is 5-10% and 30% in
adult women.(33) Adverse reactions include: contracting
rubella from the live virus in the vaccine, burning or
stinging at the site, lymphadenopathy, urticaria, rash,
malaise, sore throat, fever, headache, dizziness, nausea,
vomiting, diarrhea, polyneuritis, arthralgia, arthritis,
local pain and inflammation, erythema multiforme, cough,
rhinitis, vasculitis, anaphylaxis, syncope, optic neuritis,
retrobulbar neuritis, papillitis, Guillain-Barré Syndrome,
encephalitis, thrombocytopenia, purpura, and Chronic
Fatigue Syndrome. (34)
Rubella is most often administered in the MMR and may cause
those side effects and adverse reactions listed under
measles.
Rubella is cultured on the tissue of an aborted child; the
27th child aborted and tested due to exposure by his mother
when she was pregnant. It contains neomycin, sorbitol and
hydrolyzed gelatin.(35)
HEPATITIS B: I have been informed of the risk of my child
developing Hepatitis B viral infection, which can cause
chronic inflammation of the liver leading to cirrhosis,
liver cancer, and possibly death. I understand that my
child's risk of developing Hepatitis B is low if I am not a
carrier or infected, if my child does not engage in
promiscuous sex or use drugs. I understand that there is
antibiotic treatment for HepB and that most of those who
contract it recover.(36) I understand that the HepB vaccine
only contains strains of HepB and is not effective against
HepA, C, D, E, F, or G.
I understand that the HepB vaccine has the following side
effects and adverse reactions: induration, erythema,
swelling, fever, headache, dizziness, pain, prutitus,
ecchymosis, sweating, malaise, chills, weakness, flushing,
tingling, hypotension, flu-like symptoms, upper respiratory
illness, nausea, anorexia, abdominal pain and cramping,
vomiting, constipation, diarrhea, lymphadenopathy, pain or
stiffness in muscles and joints, arthralgia, myalgia, back
pain, rash, urticaria, petechiae, sleepiness, insomnia,
irritability, agitation, anaphylaxis, angioedema,
arthritis, tachycardia/palpitations, bronchospasm, abnormal
liver function tests, dyspepsia, migraine, syncope, paresis
neuropathy, hypothesis, paresthesis, Guillain-Barré
Syndrome, Bell's Palsy, transverse myelitis, optic
neuritis, multiple sclerosis, thrombocytopenia, eczema,
purpura, herpes zoster, erythema modosum, alopecia,
conjunctivitis, keratisis, visual disturbances, vertigo,
tinnitus, earache, and dysuria.(37) The studies only
followed patients for 4 days post-vaccination.
Engerix-B, Merck’s adult/adolescent HepB vaccine and the
Dialysis form contain thimerosal as does the combined
HepA/HepB vaccine Twinrix.. The vaccine also contains:
aluminum hydroxide, yeast protein, and phosphate
buffers.(38)
VARICELLA (CHICKENPOX): I have been informed of the risk of
my child developing chicken pox which could potentially
result in pneumonia, secondary skin or generalized
infections, or, if caught during pregnancy, birth defects
in the baby. I understand chicken pox is generally benign
in children, but results in significant lost hours at work
for parents. Chicken pox in adults often manifests as
shingles, a chronic and painful condition. I also
understand that contracting chicken pox later in life may
increase my risk for herpes simplex.
Side effects and adverse reactions for the chicken pox
vaccine include: contracting chicken pox from the live
vaccine (27%), pain and redness at site, swelling,
erythema, rash, pruritus, hematoma, induration, stiffness,
upper respiratory illness, cough, irritability/nervousness,
fatigue, disturbed sleep, diarrhea, loss of appetite,
vomiting, otitis, diaper rash/contact rash, nausea, eye
complaints, chills, lymphadenopathy, myalgia, lower
respiratory illness, headache, teething, malaise, abdominal
pain, other rash, allergic reactions including rash and
hives, stiff neck, heat rash/prickly hear, arthralgia,
eczema/dry skin/dermatitis, constipation, itching,
pneunonitis, febrile seizures, and cold/canker sore.(39)
Varicella vaccine is cultured on cells from aborted babies,
and guinea pig cell cultures. It contains live virus,
glutamate, sucrose, phosphate, processed gelatin, neomycin
and fetal calf serum. (40)
HEPATITIS A (HAV): I have been informed of the risk of my
child developing Hepatitis A (HAV), which could potentially
result in, prolonged or relapsed hepatitis, but will not
result in chronic hepatitis disease. (41) HAV usually
causes mild "flu-like" illness, jaundice, severe stomach
pains and diarrhea; and, in rare cases may result in death.
Infection confers lifelong immunity. (42) I understand that
the CDC admits that good personal hygiene (hand washing)
and proper sanitation best prevent HAV. (43)
HAV infection is spread by contaminated water or food,
infected food handlers, unsanitary conditions following
natural disasters, ingestion of raw or undercooked
shellfish, institutionalized individuals, children not yet
toilet trained, blood transfusions or sharing needles with
infected people. Transmission is most likely in developing
countries where sanitation is poor and infection rate of
children under 5 is 90%. Fatality rate is less than 0.6%
overall, and 70% of those in patients over 49 years, many
of whom have underlying liver disease. (44) Other at-risk
populations include those living on American Indian
reservations and in Alaskan Native villages, homosexually
active men, IV drug users, people using clotting factor
concentrates and international travelers. (45)
Side effects and adverse reactions from the vaccine
include: injection-site soreness, headache, fever, malaise,
induration, redness, swelling, fatigue, anorexia, nausea,
pruritis, rash, urticaria, pharyngitis, upper respiratory
tract infections, abdominal pain, diarrhea, dysgeusia,
vomiting, arthralgia, elevated cratine phosphokinase,
myalgia, lymphadenopathy, hypertonic episodes, insomnia,
photophobia, and vertigo. (46)
Aborted fetal tissue is an ingredient in the Havrix® HepA
vaccine, as is formaldehyde, aluminum hydroxide and
2-phenozyethanol.(47) A combination HepA and B vaccine,
Twinrix®, is available. (48) Twinrix is grown in human cell
cultures, contains 2-phenoxyethanol, neomycin sulfate,
polysorbate, tromentam, thimerosal and formaldehyde. (49)
PNEUMOCOCCAL - I have been informed of the risk of my child
developing pneumococcal disease, which could result in
meningitis, blood infection, pneumonia and/or ear
infections. I understand studies indicate that this vaccine
may only decrease ear infections by 9%, and only result in
a 20% reduction in chronic ear infections and ear tube
insertion in that group.
I understand my child has a 7.5:5,000 chance of developing
this disease if he or she is under age 2 and a 1:5000
chance of developing it if over age 2. Risk factors for
developing this disease are: immunoglobulin deficiency,
nephritic syndrome, Hodgkin's disease, congenital or
acquired immunodeficiency, some upper respiratory
infections, splenic dysfunctions, splenectomy or organ
transplant. This vaccine (PCV) was originally marketed for
immunocompromised children. (50) This vaccine is
contraindicated to children with thrombocytopenia,
coagulation disorders, or sensitivity to diphtheria
toxoid.(51)
Possible side effects and complications from the vaccine
include: erythema, induration, tenderness, interference of
limb movement, inflammation, fever, irritability,
drowsiness, restless sleep, decreased appetite, vomiting,
diarrhea, fussiness, rash, hives, bronchitis, asthma,
pneumonia, otitis media (ear infection), sepsis, seizure,
anaphylaxis and death.(52) Recipients were followed for 3
days and almost 10% of the subjects made a visit to the
emergency room in the follow-up period. There were 8 cases
of SIDS in the 17,066 subjects involved in the trial.(53)
Note: Children in the study's' control group received
another experimental vaccine, so there have been no trial
studies done with a placebo.(54)
Prevnar contains 0.125 mg of aluminum sulfate, protein
polysaccharides from 7 strains of strep. pneumoniae
bacteria, diphtheria toxin, casamino acids, yeast extract.
Studies indicate that it may interfere with the safety and
efficacy of other vaccines.(55)
SEASONAL FLU - I have been informed of the risk of my child
developing influenza, which could result in hospitalization
for respiratory complications, pneumonia and death. I
understand less than 175 people died from the flu in the US
during 2003. I understand that there is no guarantee that
the flu strains chosen for this year will be the flu
strains that are active this year. I understand that from
1999 - 2003, 70 - 80% of the sniffles, fevers, and body
aches did not test positive for influenza regardless of the
flu strain used.
The most common reactions to injected flu vaccines, which
begin within 12 hours of vaccination and can last several
days are: fever, fatigue, painful joints and headache. The
most serious reaction that has been associated with flu
vaccine is Guillain-Barré Syndrome (GBS), which occurs most
often within two to four weeks of vaccination. GBS is an
immune mediated nerve disorder characterized by muscle
weakness, unsteady gait, numbness, tingling, pain and
sometimes paralysis of one or more limbs or the face.
Recovery takes several months and can include residual
disability. Less than 5 percent of GBS cases end in death.
Brain and nerve disorders such as encephalopathy, optic
neuritis, partial facial paralysis, and brachial plexus
neuropathy as well as vasculitis also have been reported
following the flu vaccine, although a definite causal
relationship has not been established. (56) A tenfold
increase in Alzheimer’s disease exists for those who
receive the flu vaccine five years in a row. (57)
FluMist: Reported adverse effects in children include runny
nose, nasal congestion, cough, sore throat, headache,
irritability, decreased activity, fever, chills, muscle
aches, and vomiting. In adults the most common side effects
were runny nose, cough, sore throat, headache, muscle
aches, fever, chills and tiredness or weakness. Other
adverse events that occurred in children were abdominal
pain, asthma, bronchitis, conjunctivitis, viral syndrome,
otitis media (middle ear infection), and wheezing or
shortness of breath.(58)
Fluzone is propagated in chick embryos. It contains
formaldehyde, sucrose, polyethylene glycol, sodium
phosphate, salt and thimerosal.(59) Fluvirin is prepared in
chicken eggs and contains thimerosal, neomycin, polymyxin,
and phosphate-buffered saline. (60) FluMist is a live
vaccine propagated in chicken eggs, and contains potassium
phosphate, sucrose (table sugar) and monosodium glutamate
(MSG). (61)
HUMAN PAPILLOMAVIRUS (HPV) – I have been informed of the
risk of developing HPV. HPV is a sexually-transmitted
disease that can cause genital warts, and it’s most severe
stage, cervical cancer. I understand that there are more
than 100 forms of HPV and that the currently available
vaccine only covers four of the strains; current screening
for HPV looks for 13 “high risk” strains. The CDC estimated
that by age 50, 80% of women have already contracted and
cleared HPV and many strains cause no harm. (62) I
understand current research shows that most women will
quickly clear the infection on their own, and very few will
develop pre-cancerous or cancerous lesions. Use of the
vaccine will not cure HPV infection, and the duration of
the longest HPV vaccine studies covered less than 50% of
the time it takes to progress from CIN 2 or 3 levels to
cervical cancer, so 100% efficacy cannot realistically be
proven. (63) HPV vaccination does not take the place of
routine Pap screens. (64)
The most common reactions to the HPV vaccines were pain,
swelling, redness and itching at the injection site. More
than 90% of vaccine test subjects and more than 85% of
subjects receiving the aluminum-containing placebo
experienced at least one of these reactions. (65) Other
reactions from the vaccine included: systemic fever,
nausea, nasopharyngitis, dizziness, diarrhea, vomiting,
myalgia, numbness and tingling in the extremeties, pain and
weakness, hair loss, rashes, cough, upper respiratory tract
infection, malaise, arthralgia, insomnia, fainting, and
nasal congestion. More severe reactions included headache,
seizures, extreme fatigue, paralysis, brain inflammation,
gastroenteritis, appendicitis, pelvic inflammatory disease,
asthma, pulmonary embolism, heart attack, stroke, blood
clots, sepsis, arrhythmia, juvenile arthritis, rheumatoid
arthritis, lupus, arthritis and reactive arthritis. There
were also statistically higher levels of birth defects in
women who got pregnant within 30 days of receiving the
vaccine and in more than 30 cases of birth defects in women
who became pregnant after 30 days from either Gardasil® or
the aluminum-containing placebo. (66, 67, 68, 69)
Gardasil® is currently the only HPV vaccine approved for
use and contains 225mcg of aluminum hydroxyphosphate
sulfate, sodium chloride, L-histidine, polysorbate 80,
sodium borate, water, and virus-like particles from HPV
strains 6, 11, 16 and 18 grown in yeast fermentation
medium. (70)
H1N1 – While this vaccine is still in production phase, the
following information has been published regarding the
disease and the vaccine that should be available in
October, 2009. I have been informed of the risk of
developing H1N1 Flu (The New Swine Flu).H1N1 is a
combination swine and bird flu that also contains human
DNA. It appeared in April 2009 in Mexico and spread quickly
over the course of about six weeks. There were less than
50,000 cases worldwide, 18,000 of those in the US.
Approximately 5% of US cases required hospitalization and
there were 45 US deaths and 163 dead worldwide.(71, 72)
In August, 2009, the World Health Organization declared
H1N1 Phase 6, the highest alert staus possible (73), and
the CDC declared H1N1 a National Public Health Emergency
(74). Reports say that H1N1 has been no more virulent or
dangerous than the seasonal flu, and symptoms are difficult
to distinguish without lab tests (75).
Pre-distribution information reports that the H1N1 vaccine
in production by GSK is cultured on human liver cells(76).
The H1N1 vaccine in production from DynCorp is reported to
be cultured in live green monkey kidneys(77). The vaccines
being developed by Novartis and GSK will use Squalene as an
adjuvant, in part because it is the production method
recommended by the World Health Organization. WHO also
recommends that the H1N1 vaccine be live (78).Current
seasonal flu vaccines contain thimerosol and some reports
say at least one of the H1N1 vaccines will also (79).
As to side effects, we don’t know. These vaccines are still
in production phase and only two have begun testing phase.
GSK admits “clinical trials will be limited, due to the
need to provide the vaccine to governments as quickly as
possible. Additional studies will therefore be required and
conducted after the vaccine is made available (80). The
other manufacturers have made similar statements about
short test phases of perhaps only two weeks (81).
Reference List
1.
M.
Burnet and D. White, The Natural History of Infectious
Disease (Cambridge, 1972), p. 16.
2. Strebel, et al, "Epidemiology in the U.S. One Decade
After the Last Reported Case of Indigenous Wild Virus
Associated Disease," Clinical Infectious Diseases, (Center
for Disease Control, February 1992), pp. 568-79.
3. Physician's Desk Reference (PDR), 50th Edition; Medical
Economics, 1996, p. 1388-1390.
4. Ibid, p. 885-886 and 891-892.
5. J. Butel, et al; "Molecular Evidence of Simian Virus 40
Infections in Children", The Journal of Infectious Diseases
; September 1999;180:884-887.
6. PDR, 50th Edition, p. 872-875.
7. Ibid.
8. Ibid.
9. Richard Moskowitz, M.D., "Immunizations: The Other
Side," Mothering, (Spring1984),p. 34.
10. Immunization: Survey of Recent Research, (United States
Department of Health and Human Services, April 1983), p.
76.
11. "Nature and Rates of Adverse Reactions Associated with
DPT and DT Immunizations...," Pediatrics, Vol. 68, No. 5
(Nov. 1981).
12. Walene James, Immunization the Reality Behind the Myth,
(South Hadley, Massachusetts: Bergin & Garvey, 1988),
p. 14.
13. W.C. Torch, "Diphtheria-pertussis-tetanus (DPT)
immunization: A potential cause of sudden infant death
syndrome (SIDS)," (Amer. Academy of Neurology, 34th Annual
Meeting, Apr 25 - May 1, 1982), Neurology 32(4), pt. 2.
14. PDR, p. 875-879 and 892-895.
15. Ibid.
16. Robert Mendelsohn, M.D., How to Raise A Healthy
Child...In Spite of your Doctor (Chicago: Contemporary
Books, 1984), p.223.
17. Ibid. 244-246
18. Isaac Golden, Ph.D., Vaccination? A Review of Risks and
Alternatives, (Geelong, Victoria, Australia: Arum Healing
Centre, 1991), p. 31
19. Richard Moskowitz, M.D., "Immunizations: The Other
Side," Mothering, (Spring1984),p. 34.
20. Isaac Golden, Ph.D., Vaccination? A Review of Risks and
Alternatives; p. 71
21. R. Mendelsohn; How to Raise a Healthy Child; p. 217.
22. John Frank Jr., M.D., et al. "Measles Elimination -
Final Impediments," 20th Immunization Conference
Proceedings, May 6-9, 1985, p. 21.
23. Infectious Diseases (January 1982), p. 21.
24. PDR, p. 1610-1611.
25. PDR, p. 1687-1689.
26. Sara Solovitch, "Do vaccines spur autism in kids?", San
Jose Mercury News, 5/25/99.
27. PDR, p. 1687-89, 1610-1611.
28. Richard Moskowitz, M.D., "Immunizations: The Other
Side," Mothering, (Spring1984),p. 35.
29. PDR, 1708-1709.
30. Ibid.
31. R. Mendelsohn; How to Raise a Healthy Child; p. 218.
32. Dr. Beverley Allan, Australian Nurses Journal, (May
1978).
33. Hannah Allen, Don't Get Stuck: The Case Against
Vaccinations..., (Oldsmar, FL: Natural Hygiene Press,
1985), p. 144.
34. PDR, p. 1697-1699.
35. Ibid and Attenuation Of RA 27/3 Rubella Virus in WI-38
Human Diploid Cells; Amer J Dis Child vol 118 Aug 1969 and
Studies of Immunization With Living Rubella Virus ; Arch J
Dis Child vol 110 Oct 1965.
36. John Hanchette, "Safety of controversial hepatitis B
vaccine at center of debate" Gannett News Service, 5/18/99.
37. PDR, p. 1744-1747, 2482-2484.
38. Ibid.
39. PDR, p. 1762-1765.
40. Ibid.
41. CDC Viral Hepatitis A - Fact Sheet, 9/29/00;
www.cdc.gov/ncidod/diseases/hepatitis/a/fact.htm
42. CDC Hepatitis A Vaccine Vaccine Information Statement;
8/25/98
43. CDC Hepatitis A Facts, 11/16/00
44. Mosby's GenRX®, 10th Ed., Hepatitis A Vaccine (003158)
as posted on MDConsult website
45. CDC Hepatitis A Vaccine Vaccine Information Statement;
CDC Hepatitis A Vaccine Vaccine Information Statement;
8/25/98
46. Mosby's GenRX@, Hepatitis A Vaccine
47. Ibid.
48. "Combined hepatitis A/B vaccine offers fast
protection," Reuters Health, 4/12/00
49. Vaccines and Their Ingredients, 6/24/99;
www.909shot.com
50. Michael Horwin, MA; "Prevnar: A Critical Review of a
New Childhood Vaccine" 9/19/00.
51. Prevnar package insert, Wyeth Lederle, 2/17/00
52. Ibid.
53. Horwin; "Prevnar: A Critical Review"
54. Dr. Erdem Cantekin, Ph.D.; "Pneumococcal Vaccine and
Otitis Media", NVIC's 2nd Intl. Public Conference, 9/8/00.
55. Horwin; "Prevnar: A Critical Review"
56. Physician's Desk Reference (PDR), 53rd Edition; Medical
Economics, 1999, p. 2326, 3464
57. Dr. Russell Blaylock, MD; “The Truth Behind the Vaccine
Coverup” 9/22/04; www.mercola.com/2004/sep/22/blaylock_vaccine_coverup.htm
57. Fluzone 2003-2004 Formula, Aventis Product information
as of July 2003
58. Dr. Sherry Tenpenny, DO, “FluMist Vaccine: Nothing to
Sneeze At!” 10/23/2003; www.nmaseminars.com
.
59. Influenza Virus Vaccine Live, Intranasal FluMist
2003-2004 Formula, Package Insert (Circular) June 16, 2003.
60. “New Preservative Free Flu Vaccine Approved,”
http://www.accessdata.fda.gov/psn/transcript.cfm?show=10
61. Dr. Sherry Tenpenny, DO, “FluMist Vaccine: Nothing to
Sneeze At!”
62. CDC HPV Fact Sheet, http://www.cdc.gov/std/HPV/STDFact-HPV.htm
63.
Dr. Clayton Young, MD, FACOG, “OBGYN Against ACIP HPV
Vaccine Decision,” 6/27/2006
64. CDC HPV Fact Sheet, http://www.cdc.gov/std/HPV/STDFact-HPV.htm
65.
Merck Professional Privider Information Sheet: Gardasil®
[Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18)
Recominant Vaccine. www.Merck.com
66. Daron G Ferris, “Facing the Future: The Impact of HPV
Vaccination on Adolescent Health,” and “An Update of
Clinical Trial Results With Preventative HPV
Vaccines” http://www.medscape.com/viewprogram/5334
67.
CDC, Reprots of Health Concerns Following HPV Vaccination,
June 10, 2009
68.
Attkusson, S, New Worries About Gardasil Safety: Vaccine
Safety Group Study Shows Higher Incidence of Medical Side
Effects Than Another Vaccine, CBS Evening News, Feb. 6,
2009.
69.
Fisher,
BK, Devold V, An Anaylsis by the National Vaccine
Information Center of Gardasil and Menactra Adverse Events
Reports to the Vaccine Adverse Events Reporting System
(VAERS), NVIC, Feb. 2009.
70. Merck Professional Provider Information Sheet:
Gardasil® [Quadrivalent Human Papillomavirus (Types 6, 11,
16, 18) Recominant Vaccine. www.Merck.com
71 World Health Organization. Epidemic and Pandemic Alert
and Response: Influenza A (H1N1), Situation Update and
Maps. June 15, 2009 (Update 49). http://www.who.int/csr/don/2009_06_15/en/index.html
72 Centers for Disease Control. Novel H1N1 Flu Situation
Update (June 12, 2009). http://www.cdc.gov/h1n1flu/update.htm
73. World Health Organization. Statement to media by
Margaret Chan, M.D.: World now at the start of 2009
influenza pandemic. June 11, 2009. http://www.who.int/mediacentre/news/statements/2009/
h1n1_pandemic_phase6_20090611/en/index.html
74. Department of Homeland Security. Homeland Security
Advisory System. http://www.dhs.gov/xabout/laws/gc_1214508631313.shtm
75. http://articles.mercola.com/sites/articles/archive/2009/08/13/Swine-Flu-Vaccine-Makers-to-Profit-50-Billion-a-Year.aspx
76.
Ibid,
77. Adams, M, “Diseased African Monkeys Used to Make Swine
Flu Vaccines; Natural News Editor, Aug. 9, 2009.
78.
Mercola, J, “Swine Flu is NOT the Problem – It is the
Vaccine that May Harm or Kill You,” mercola.com, 8/11/09
79.
http://articles.mercola.com/sites/articles/archive/2009/08/13/Swine-Flu-Vaccine-Makers-to-Profit-50-Billion-a-Year.aspx
80. Wachman, R, “Drug Giant GlaxoSmithKline Predicts Swine
Flu Gold Rush, guardianco.uk, 7/22/09
81. Food and Drug Administration, Center for Biologics
Evaluation and Research, Office of Vaccine Research and
Review. Regulatory
Considerations Regarding the Use of Novel Influenza A
(H1N1) Virus Vaccines. July 23, 2009.
Compiled 10/18/99, updated 8/14/2009 by Kathy Barr.
Email:
AboundingHealth@aol.com
Contact
Information:
Kathy
Barr, CCD, CCCE, CCM, BE, PE, CVE, Traditional Naturopath
817-819-8457
